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Objectives. This study sought o assess a test performance of the 
electrocardiogram (ECG) in relation to 1) varying definitions of 
left ventricular hypertrophy based on different methods of adjust- 
ing left ventricular mass for body size, and 2) the presence or 
absence of obesity. 
Background. Although left ventricular mass is most commonly 
indexed for body surface area or height when defining left 
ventricular hypertrophy, recent work suggests that normalization 
for height to the power of 2.7 (height z'7) may decrease variability 
among normal subjects and correctly identify the impact of 
obesity on hypertrophy. 
Methods. The product of Cornell voltage and QRS duration 
(Cornell product) and Framingham-adjusted Cornell voltage were 
determined from 12-lead ECGs in 212 patients. Left ventricular 
hypertrophy was defined on the basis of left ventricular mass 
indexed to body surface area, height and height 2"7. 
Results. Using partitions with matched specificity of 95%, the 
sensitivity of ECG criteria varied with the definition of hypertro- 
phy, ranging from 39% to 52% for the Cornell product and from 
24% to 33% for adjusted Cornell voltage. When left ventricular 
mass was indexed to body surface area or to height 2'7, the 52% and 
39% sensitivities of the Cornell product were significantly greater 
than the 24% (p < 0.001) and 29% (p < 0.05) sensitivities of 
adjusted Cornell voltage, with a similar trend when left ventricu- 
lar mass was indexed to height (43% vs. 33%, p = 0.10). 
Comparison of receiver operating characteristic curves confirmed 
the superior overall performance of the Cornell product relative to 
adjusted Cornell voltage for hypertrophy defined by body surface 
area and height 2"7 and demonstrated greater reproducibility of 
overall performance, as measured by the coefficient of variability, 
for the Cornell product (1.7%) than for adjusted Cornell voltage 
(5.8%). Sensitivity of adjusted Cornell voltage was significantly 
greater in obese than in nonobese subjects (50% to 59% vs. 18% to 
24%, p < 0.01), but the Cornell product had only minimally higher 
sensitivity in nonobese than in obese subjects (40% to 54% vs. 32% 
to 44%, p = NS). 
Conclusions. The ability of ECG criteria to detect left ventric- 
ular hypertrophy differs depending on the method of indexing left 
ventricular mass for body size and with the presence or absence of 
obesity. Further, the Cornell product provides the best combina- 
tion of overall accuracy and low variability of performance 
between definitions of hypertrophy. These findings have impor- 
tant implications for the clinical and epidemiologic use of 12-lead 
ECG criteria for the detection of left ventricular hypertrophy. 
(J Am Coil Cardiol 1996;27:124-31) 
The presence of increased left ventricular mass detected by 
echocardiography as been associated with increased risk of 
cardiovascular morbidity and mortality among members of the 
general population (1,2) and in patients with hypertension 
(3,4) or coronary artery disease (5), making accurate and 
cost-effective detection of increased left ventricular mass a 
clinical priority (6). Although standard 12-lead electrocardio- 
graphic (ECG) evidence of left ventricular hypertrophy is also 
associated with an increased risk of adverse cardiovascular 
outcome (7-10), accurate, widespread utilization of the ECG 
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for the detection of hypertrophy has been limited by the poor 
sensitivity at acceptable l vels of specificity of current ECG 
criteria (11-20). However, new approaches to analysis of the 
12-lead ECG based on adjustment of QRS amplitude for age 
and obesity (18) or on an approximation of the area under the 
QRS complex (19,20) may increase test accuracy. 
Although left ventricular mass is most commonly indexed to 
body surface area or height when defining left ventricular 
hypertrophy (1-3,21-24), recent work suggests that normaliza- 
tion for height o the 2.7 power (height 27) decreases variability 
and reduces the impact of obesity on determination of hyper- 
trophy (24) and may improve the prediction of adverse prog- 
nosis (25). Because quantitative measurements of left ventric- 
ular mass at autopsy or by echocardiography are the standards 
against which performance of the ECG for detection of 
hypertrophy is measured, it is apparent hat accuracy of the 
ECG for detection of left ventricular hypertrophy may vary 
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both according to the ECG criteria used and how left ventric- 
ular mass is indexed to body size in the definition of hypertro- 
phy. Therefore, the present study was designed to test the 
performance and the variability of performance of ECG 
criteria in relation to varying definitions of left ventricular 
hypertrophy based on different methods of indexing left ven- 
tricular mass for body size and to assess the effect of obesity on 
ECG sensitivity. 
Methods  
Study group. Cases were selected from review of the 
autopsy log of the Hospital of the University of Pennsylvania 
and of The New York Hospital-Cornell Medical Center, as 
previously described (19). Complete clinical data and 12-lead 
ECGs of adequate technical quality in a nonpaced rhythm 
obtained within a mean of 16 days of death were available for 
a total of 212 patients (113 men, 99 women; mean [_+SD] age 
60 _+ 16 years). Women with a left-sided mastectomy were 
excluded because the decreased distance from the heart o the 
chest surface has been shown to increase ECG voltage out of 
proportion to left ventricular mass (26,27). Forty-one subjects 
(19%) had a body mass index exceeding partition values used 
to recognize overweight status (28,29) (27.8 kg/m 2 in men, 
27.3 kg/m 2 in women) and were considered overweight o 
mildly obese (24). 
Electrocardiography, Standard 12-lead ECGs were re- 
corded at 25 mm/s and 1-mV/cm standardization with equip- 
ment having frequency response characteristics in accordance 
with American Heart Association recommendations (30). 
Tracings were coded and interpreted by a single investigator 
who had no knowledge of clinical or autopsy findings. QRS 
duration was measured to the nearest millisecond and QRS 
amplitudes to the nearest microvolt on digitized ECGs (n = 
117); analog ECGs were measured to the nearest 10 ms and 
nearest 0.5 mm (50/zV), respectively, with use of a magnifying 
graticle (n = 95). 
Two widely used simple voltage criteria for detection of left 
ventricular hypertrophy were examined: 1) the Sokolow-Lyon 
voltage (sum of the amplitude of the S wave in lead V 1 and the 
R wave in lead V5 or V6) (31), and 2) the gender-specific 
Cornell voltage (sum of the R wave in lead aVL and the 
amplitude of the S wave in lead V3 adjusted by the addition of 
8 mm [0.8 mV] in women) (12,19). Several variations of the 
Cornell ECG criteria were also examined: 1) the Cornell 
voltage-duration product (gender-specific Cornell voltage 
times QRS duration) (19,20); 2) the Cornell multivariate 
regression score (9), a weighted score that incorporates QRS 
duration, QRS voltages, repolarization changes and P wave 
abnormalities; and 3) the gender-specific adjusted Cornell 
voltage (18), adjusted for age and body mass index, a measure 
of obesity, according to regression equations derived in a 
cohort of the Framingham study (18). Two additional complex 
ECG criteria that incorporate QRS duration, QRS amplitudes, 
repolarization abnormalities and P wave findings were also 
examined: 1) the Romhilt-Estes point score (32), and 2) the 
gender-specific Novacode regression equations of Rautaharju 
et al. (17). 
Left ventricular mass and determination of hypertrophy. 
Left ventricular mass was measured by the chamber partition 
method (33) and was indexed to body surface area, height and 
height z7. When left ventricular mass was indexed to body 
surface area, left ventricular hypertrophy was defined as left 
ventricular mass index >118 g/m 2 in men and >104 g/m 2 in 
women, which approximates the upper 97th percentile of 
normal eft ventricular mass index in a subset of 39 autopsy 
studies from patients with neither intrinsic disease nor hemo- 
dynamic load affecting the left ventricle (12). Left ventricular 
mass/height >143 g/m in men or >102 g/m in women was 
considered to represent hypertrophy (18,21), as was left ven- 
tricular mass/height 27 >50 g/m 2"7 in men or >47 g/m 27 in 
women (24). 
Data analysis and statistical methods. The strength of the 
relations between ECG criteria and left ventricular mass 
indexed according to each method was assessed by Pearson 
correlation coefficients. Differences in coefficients of correla- 
tion were compared statistically by two-tailed tests after apply- 
ing the Fisher Z transformation. Definitions of test sensitivity 
and specificity conform to standard use (34). Test sensitivity of 
the Cornell product for the identification of left ventricular 
hypertrophy according to each method of indexing left ventric- 
ular mass for body size was compared with the other ECG 
criteria at partitions with matched specificities of 95% using 
the McNemar modification of the chi-square method for 
paired proportions. Because sensitivity and specificity of a test 
are dependent on the partition value chosen for test positivity, 
overall test accuracy was compared by receiver operating 
characteristic (ROC) curve analysis, which compares test per- 
formance over a wide range of possible partition values to 
identify differences in test performance between methods 
independent of empirically derived criteria (35). The ROC 
curves were compared statistically by means of a two-tailed 
univariate Z test of the difference between the areas under two 
performance urves (36). 
Variability of measurements of correlation and of the area 
under performance urves as a function of how left ventricular 
mass was indexed was expressed as the coefficient of variability, 
in percent (i.e., the standard eviation divided by mean 
measurement multiplied by 100). For all comparisons, p < 0.05 
was required for rejection of the null hypothesis. 
Resu l ts  
Study group. The prevalence of left ventricular hypertro- 
phy in the overall cohort varied significantly according to the 
method of indexing left ventricular mass for body size. The 
prevalence of hypertrophy was highest (43%) when left ven- 
tricular mass was adjusted by body surface area, similar (42%) 
when mass was indexed to height 2"7 and significantly lower 
(38%) when mass was indexed to height (p < 0.05 for each 
comparison). 
Characteristics of the study subjects in relation to the 
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Table 1. Demographic Variables in Relation to Presence or Absence of Left Ventricular Hypertrophy According to Method of Indexing 
Ventricular Mass for Body Size 
LV Mass Indexed to BSA LV Mass Indexed to Height LV Mass Indexed to Height 27 
No LVH LVH No LVH LVH No LVH LVH 
(n = 120) p Value (n = 92) (n = 131) p Value (n 81) (n = 122) p Value (n = 90) 
Age (yr) 58 _+ 16 0.004 64 _+ 14 59 + 16 0.03 63 + 14 58 _+ 16 0.02 63 _+ 15 
M/F (no.) 65/55 NS 48/44 79/52 0.01 34/47 69/53 NS 44/46 
Height (cm) 167 _+ i0 NS 166 + 12 168 + 11 NS 166 _+ 11 169 + 10 0.01 165 _+ 11 
Weight (kg) 67 _+ 17 NS 65 _+ 15 64 +_ 16 NS 68 _+ 17 65 _+ 16 NS 67 _+ 16 
BSA (m 2) 1.75 _+ 0.23 NS 1.71 _+ 0.22 1.72 + 0.23 NS 1.75 _+ 0.23 1.74 _+ 0.23 NS 1.72 _+ 0.22 
BMI (kg/m 2) 23.8 _+ 5.7 NS 23.4 _+ 5.0 22.8 _+ 5.0 0.008 24.8 _+ 5.8 22.8 _+ 5.1 0.02 24.6 + 5.6 
Obesity (%) 19 NS 20 15 0.03 27 15 0.05 26 
Data presented are mean value _+ SD, unless otherwise indicated. BMI = body mass index; BSA - body surface area; F = female; LV - left ventricular; LVH = 
left ventricular hypertrophy; M = male. 
presence or absence of left ventricular hypertrophy for each 
definition of hypertrophy are presented in Table 1. Indepen- 
dent of how left ventricular mass was indexed for body size, 
subjects with hypertrophy were older than those without 
hypertrophy but were similar in weight and body surface area. 
Gender distribution was similar in subjects with and without 
hypertrophy when left ventricular mass was indexed to body 
surface area or height 27, but there was a greater proportion of 
women in the group with hypertrophy when mass was indexed 
to height. When left ventricular mass was indexed to body 
surface area, there was no significant difference in body mass 
index or in the prevalence of mild obesity between subjects 
with and without hypertrophy. In contrast, subjects with left 
ventricular hypertrophy defined by left ventricular mass in- 
dexed to height or height 27 had a higher body mass index and 
a greater prevalence ofobesity than subjects without hypertro- 
phy. 
Linear correlations ofECG criteria. The linear correlation 
of ECG criteria with indexed left ventricular mass according to 
each method of indexation and the variability of correlation as 
a function of the method of normalization are shown in Table 
2. All ECG criteria exhibited modest correlations with indexed 
left ventricular mass, with the Cornell product and Cornell 
multivariate score having the highest correlation coefficients 
and the Novacode score having the lowest coefficients of 
correlation for each method of indexing mass. Most of the 
ECG criteria exhibited relatively similar levels of linear corre- 
lation for each method of indexed left ventricular mass. As a 
consequence, variability of correlation as a function of the 
method of indexation was generally low and was lowest for the 
Cornell multivariate score (1.2%) and Cornell product (2.9%). 
In contrast, linear correlation of adjusted Cornell voltage was 
more highly dependent on the method of indexing left ventric- 
ular mass, with a much higher coefficient of variability (23.0%) 
than the other ECG criteria. 
The greater variability of correlation of adjusted Cornell 
voltage compared with the other ECG criteria reflects the 
variable relation of these ECG criteria to unindexed left 
ventricular mass, height, weight and body surface area (Table 
3). Similar to findings with indexed left ventricular mass, the 
Cornell product and multivariate score exhibited the strongest 
and the Novacode the weakest positive correlations with 
unindexed mass. In addition, there were striking differences in
the strength and direction of linear correlation of ECG criteria 
with height, weight and body surface area. Adjusted Cornell 
voltage exhibited a modest but significant negative linear 
correlation with height and stronger positive correlations with 
weight than with ventricular mass. Simple Cornell voltage had 
a similar inverse relation to height but had only weak and 
negative correlations with weight and body surface area. In 
Table 2. Linear Correlations and Variability of Correlations of Electrocardiographic Criteria for Left Ventricular Mass Indexed to Body 
Surface Area, Height and Height 27 
Correlation Coefficient 
Coefficient of 
LV Mass Indexed to LV Mass Indexed to LV Mass Indexed to Correlation Coefficient Variability 
Criteria Body Surface Area Height Height 27 (mean +_ SD) (%) 
Sokolow-Lyon voltage 0.428* 0.391" 0.381 * 0.400 _+ 0.025 6.3 
Cornell voltage 0.478t 0.444t 0.493 0.471 _+ 0.025 5.3 
Adjusted Cornell voltage 0.3025 0.414t 0.485 0.400 _+ 0.092 23.0 
Cornell product 0.576 0.546 0.555 0.559 _+ 0.016 2.9 
Romhilt-Estes point score 0.452t 0.439t 0.424t 0.438 _+ 0.014 3.2 
Novacode score 0.3445 0.3225 0.3195 0.328 _+ 0.014 4.3 
Cornell multivariate score 0.598 0.584 0.592 0.592 _+ 0.007 1.2 
*p < 0.01, tp < 0.05, 5p < 0.001 versus Cornell product, All correlation coefficients ignificant at p < 0.0001. LV = left ventricular. 
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Table 3. Linear Correlations ofElectrocardiographic Cr teria for Left Ventricular Mass and Measures 
of Body Size 
Correlation Coefficient (p value) 
Criteria LV Mass Height Weight Body Surface Area 
Sokolow-Lyon voltage 0.379* -0.029 -0.132 -0.108 
(<0.0001) (0.672) (0.055) (0.116) 
Cornell voltage 0.399* 0.193 0.127 -0.157 
(<0.001) (0.005) (0.065) (0.022) 
Adjusted Cornell voltage 0.361" -0.218 0.478t 0.300:~ 
(<0.001) (0.001) (<0.001) (<0.001) 
Cornell product 0.519 -0.059 -0.081 -0.066 
(<0.001) (0.391) (0.242) (0.337) 
Romhilt-Estes point score 0.429* 0.033 0.021 0.013 
(<0.001) (0.638) (0.767) (0.852) 
Novacode score 0.311 $ -0.066 -0.111 -0.094 
(<0.001) (0.342) (0.109) (0.171) 
Cornell multivariate score 0.557 -0.057 -0.034 0.026 
(<0.001) (0.407) (0.619) (0.707) 
*p < 0.05, tp < 0.001, Sp < 0.01 versus Cornell product. LV = left ventricular. 
contrast, none of the other ECG criteria had statistically 
significant linear correlations with height, weight or body 
surface area. 
Performance of ECG criteria in detection of left ventricular 
hypertrophy. The sensitivity and overall performance ofECG 
criteria for the identification of left ventricular hypertrophy in 
relation to the method of indexing left ventricular mass are 
examined in Tables 4 and 5. Test performance of simple and 
adjusted Cornell voltage, relative to the Cornell product, 
varied with the definition of hypertrophy. When hypertrophy 
was defined by left ventricular mass/body surface area, the 52% 
sensitivity of the Cornell product was significantly greater than 
the 45% sensitivity of simple Cornell voltage and than the 24% 
sensitivity of adjusted Cornell voltage. For hypertrophy de- 
fined by left ventricular mass/height, the 43% sensitivity of the 
Cornell product was significantly greater than the 35% sensi- 
tivity of Cornell voltage with a trend toward increased accuracy 
compared with the 33% sensitivity of adjusted Cornell voltage 
Table 4. Sensitivity ofElectrocardiographic Cr teria for Left 
Ventricular Hypertrophy in Relation to Method of Indexation of
Left Ventricular Mass Using Partitions With Matched Specificities 
of 95% 
Sensitivity (%) for LVH Defined by LV Mass 
Indexed to Measures of Body Size 
Criteria Body Surface Area Height Height z7 
Sokolow-Lyon voltage 30* 22* 22t 
Cornell voltage 452 355 36 
Adjusted Cornell voltage 24* 33 29~ 
Cornell product 52 43 39 
Romhilt-Estes point score 27* 23* 23? 
Novacode score 23* 17' 217 
Cornell multivariate score 46 37 38 
*p < 0.001, tp < 0.01, Sp < 0.05 versus Cornell product. LV - left 
ventricular; LVH = left ventricular hypertrophy. 
(p = 0.10). When left ventricular mass was indexed to 
height 2"7, the 39% sensitivity of the Cornell product was 
significantly greater than the 29% sensitivity of adjusted Cor- 
nell voltage but only slightly higher than the 36% sensitivity of 
simple Cornell voltage. Comparison of ROC curve areas 
(Table 5) confirmed the superior overall performance of the 
Cornell product relative to adjusted Cornell voltage for left 
ventricular hypertrophy defined by normalization to body 
surface area and height 27 and further demonstrated that 
overall performance of the Cornell product was greater than 
simple Cornell voltage for each definition of hypertrophy. In
contrast, test performance of Sokolow-Lyon voltage and the 
multivariate scores relative to the Cornell product did not vary 
significantly with a changing definition of hypertrophy. Sensi- 
tivity and overall performance of the Cornell product were 
significantly higher than that found for Sokolow-gyon voltage, 
Romhilt-Estes point score and Novacode score and were 
similar to that of the Cornell multivariate score, independent 
of how left ventricular mass was indexed for body size (Tables 
4 and 5). 
Variability of overall performance of ECG criteria in 
relation to the definition of left ventricular hypertrophy is
examined in Table 5. Overall performance of simple Cornell 
voltage and the Cornell product varied only slightly with the 
definition of hypertrophy, producing the lowest coefficients of 
variability (1.0% and 1.7%). In contrast, performance of the 
Romhilt-Estes point score and adjusted Cornell voltage were 
more highly dependent on the method of indexing left ventric- 
ular mass, with coefficients of variability of 5.6% and 5.8%, 
respectively. 
Effect of obesity on performance of ECG criteria. The 
relation of the sensitivity of ECG criteria for the identification 
of left ventricular hypertrophy to the presence or absence of 
obesity according to the different methods of indexing left 
ventricular mass is shown in Table 6. Independent of how 
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Table 5. Overall Performance and Variability of Performance Defined by Receiver Operating Characteristic Curve Areas of 
Electrocardiographic Criteria for Left Ventricular Hypertrophy in Relation to Method of Indexation of Left Ventricular Mass 
ROC Curve Areas for LVH Defined by LV Mass Indexed 
to Measures of Body Size Coefficient of 
Body Surface ROC Curve Area Variability 
Criteria Area Height Height 27 (mean ± SD) (%) 
Sokolow-Lyon voltage 0.725* 0.686* 0.701' 0.704 ± 0.016 2.3 
Cornell voltage 0.775* 0.774? 0.760? 0.770 + 0.008 1.0 
Adjusted Cornell voltage 0.698~: 0.779 0.765t 0.747 + 0.043 5.8 
Cornell product 0.821 0.799 0.794 0.805 + 0.014 1.7 
Romhilt-Estes point score 0.777t 0.714' 0.700* 0.730 ± 0.041 5.6 
Novacode score 0.704* 0.679* 0.653:]: 0.679 _+ 0.026 3.8 
Cornell multivariate score 0.842 0.807 0.799 0.816 ± 0.023 2.8 
*p < 0.01, ?p < 0.05, Sp < 0.001 versus Cornell product. ROC = receiver operating characteristic; other abbreviations a  Table 4. 
hypertrophy was defined, Cornell voltage adjusted for age and 
body mass index demonstrated significantly higher sensitivities 
in obese than in nonobese subjects. In contrast, there were 
trends toward higher sensitivities in the nonobese subjects for 
the remaining ECG criteria that did not achieve statistical 
significance, except for the higher sensitivity of Sokolow-Lyon 
voltage in nonobese subjects when left ventricular mass was 
indexed to body surface area. Among nonobese subjects, the 
40% to 54% sensitivities of the Cornell product were signifi- 
cantly greater than the 18% to 24% sensitivities of adjusted 
Cornell voltage for each definition of hypertrophy (each p < 
0.001). In contrast, among obese subjects, sensitivity of ad- 
justed Cornell voltage was significantly greater than that of the 
Cornell product when left ventricular mass was indexed to 
height, with trends toward increased sensitivity when hypertro- 
phy was defined according to indexation to body surface area 
or height 27. The strong relation of sensitivity of adjusted 
Cornell voltage to body habitus is further accented by its 
significantly lower sensitivity in markedly underweight subjects. 
In contrast o the increased sensitivity of adjusted Cornell 
voltage in obese subjects, ensitivity of adjusted Cornell voltage 
in subjects below the fifth percentile of gender-specific body 
mass index partitions (29) ranged from only 0% to 13% for 
each definition of left ventricular hypertrophy, significantly 
lower than the 60% to 72% sensitivities of the Cornell product 
(p < 0.05 to p < 0.01). Furthermore, sensitivity of the Cornell 
product was significantly greater than sensitivity of Sokolow- 
Lyon voltage, Romhilt-Estes point score and Novacode score, 
independent of the presence or absence of obesity for each 
definition of hypertrophy. 
Discuss ion  
The present findings demonstrate that performance of 
ECG criteria for the identification of left ventricular hypertro- 
phy varies according to the method of normalizing left ventric- 
ular mass for body size and with the presence or absence of 
obesity. These data further demonstrate that the Cornell 
product provides the best combination of overall accuracy and 
low variability of performance between definitions of hyper- 
trophy relative to simple and adjusted Cornell voltage and to 
complex, multivariate ECG scores. These findings have impor- 
tant implications for the use of 12-lead ECG criteria for the 
detection of left ventricular hypertrophy in clinical and epide- 
miologic studies. 
Electrocardiographic detection of left ventricular hypertro- 
phy: relation to definition of hypertrophy. Although numer- 
ous ECG criteria have been reported and compared for the 
Table 6. Sensitivity of Electrocardiographic Criteria for Left Ventricular Hypertrophy in Relation to Presence or Absence of Obesity 
According to Method of Indexation of Left Ventricular Mass Using Partitions With Matched Specificities of 95% 
Sensitivity (%) for LVH Defined by LV Mass Indexed to Measures of Body Size 
Criteria 
Body Surface Area Height Height 27 
Obese Nonobese Obese Nonobese Obese Nonobese 
(n = 18) (n = 74) (n = 22) (n = 59) (n - 23) (n = 67) 
Sokolow-Lyon voltage 11 35* 9 27 9 27 
Cornell voltage 39 46 27 37 30 37 
Adjusted Cornell voltage 50 18t 59 24~ 52 21? 
Cornell product 44 54 32 47 35 40 
Romhilt-Estes point score 22 28 18 25 17 25 
Novacode score 11 26 5 22 9 25 
Cornell multivariate score 44 46 27 41 35 39 
*p < 0.05, tp < 0.01 versus obese subjects. Abbreviations as in Table 4. 
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detection of left ventricular hypertrophy (11-20,31), various 
reference standards for hypertrophy and differing methods of 
normalizing left ventricular mass for body size have been 
utilized in the derivation and testing of these criteria. Cornell 
voltage criteria and the Cornell multivariate criteria were 
derived in relation to left ventricular mass indexed to body 
surface area using both echocardiographic (11) and autopsy 
(12) left ventricular mass determinations, as was the more 
recently derived Cornell product (19,20). In comparison, ad- 
justed Cornell voltage criteria were derived using a multivari- 
ate regression equation in which echocardiographic left ven- 
tricular mass adjusted for height was the dependent variable 
(18). The Romhilt-Estes point score was initially tested against 
autopsy left ventricular mass adjusted for height (32), and the 
Novacode multivariate score was derived using radiographi- 
cally determined left ventricular size as the dependent variable 
(17). As a result, test performance might be expected to vary 
when these criteria are applied for the detection of left 
ventricular hypertrophy defined in different ways. 
To our knowledge, this is the first study to critically examine 
the relation of test performance of ECG criteria for the 
detection of hypertrophy to the method of normalizing left 
ventricular mass for body size. These data illustrate that test 
performance of these criteria varies importantly with the 
definition of left ventricular hypertrophy and that, in general, 
test sensitivity and overall performance tend to be greatest 
when hypertrophy is defined according to the technique used 
in the original derivation of the criteria. Thus, Cornell voltage, 
the Cornell product and the Cornell multivariate score had 
their highest accuracy when left ventricular mass was indexed 
to body surface area, whereas adjusted Cornell voltage per- 
formed best when tested against left ventricular mass/height. 
As a consequence, r lative performance ofthe Cornell product 
and adjusted Cornell voltage for the identification of left 
ventricular hypertrophy also varied as a function of how left 
ventricular mass was corrected for body size, with significantly 
greater performance of the Cornell product when hypertrophy 
was defined by left ventricular mass indexed to body surface 
area or height 27 but only a trend toward increased accuracy 
when mass was indexed to height. Varying definitions of left 
ventricular hypertrophy may in part account for differences in
the relative performance of adjusted and unadjusted Cornell 
voltages found in previous analyses (18,37). Independent of 
hypertrophy definition, Sokolow-Lyon voltage, Romhilt-Estes 
point score and Novacode score had significantly poorer 
sensitivity and overall performance for the identification of left 
ventricular hypertrophy, limiting their clinical utility. 
Reproducibility of performance for the detection of left 
ventricular hypertrophy and of linear correlation with indexed 
left ventricular mass varied importantly among the different 
ECG criteria as a function of the method of indexing mass for 
body size. Among the criteria with the better overall accuracy, 
the greater variability of adjusted Cornell voltage in compari- 
son to simple Cornell voltage criteria, the Cornell product and 
the Cornell multivariate score most likely reflects the stronger 
relation of adjusted Cornell voltage to measures of body size. 
The inverse relation of adjusted Cornell voltage with height 
and positive correlations of it with body surface area and, 
especially, weight are not surprising in light of the inclusion of 
body mass index in the regression equation used to calculate 
adjusted Cornell voltage (18). In contrast, he Cornell product 
exhibited no significant correlations with height, weight or 
body surface area. 
Relation of test performance to obesity. Obesity has been 
demonstrated to be associated with the presence of left 
ventricular hypertrophy (38,39) and, conversely, with de- 
creased sensitivity of the ECG for hypertrophy (15,18,40) due 
to the attenuating effects of obesity on QRS amplitudes 
(15,18). Although adjusted Cornell voltage criteria were devel- 
oped in part to improve ECG performance by taking the 
relation of Cornell voltage to body mass index into account 
(18), test performance of these criteria in relation to obesity 
was not examined. The current study demonstrates that, 
independent of the varying abilities of the different methods of 
indexing left ventricular mass for body size to correctly adjust 
for the effects of obesity on left ventricular hypertrophy (24), 
adjusted Cornell voltage appears to overcorrect for obesity, 
with significantly greater sensitivities in obese subjects and 
lower sensitivities in underweight subjects. In contrast, most 
other ECG criteria examined had a slightly lower sensitivity 
and the Novacode score exceptionally ow sensitivity in obese 
subjects. The relation of test performance to obesity was 
similar among men and women. The increased sensitivity of 
adjusted Cornell voltage among obese subjects clearly reflects 
the greater correlation with height and weight of these criteria 
(Table 3), which were derived to take advantage of the known 
relation of left ventricular hypertrophy to obesity (18,38,39). 
These observations suggest hat the relative performance of 
adjusted and unadjusted Cornell criteria will vary with the 
prevalence of obesity in the study group and provide a 
potential explanation for the greater overall performance of 
adjusted Cornell voltage in the Framingham cohort (18), in 
which body mass index was substantially higher than in the 
current study. 
Limitations of the study. Although the current study ex- 
amined three different methods of indexing left ventricular 
mass for body size, the clinically most useful method remains 
to be determined (24,25,41). In addition to the methods of 
normalizing left ventricular mass used in the current study, 
indexing left ventricular mass to height o the 2.0 power (41) or 
to body surface area to the 1.5 power (24) have also been 
proposed. However, similar differences in test sensitivity and 
similar degrees of variability of performance were obtained if 
ECG criteria were also examined in relation to definitions of 
hypertrophy based on these alternative methods of normaliz- 
ing left ventricular mass. In addition, the current study deter- 
mined left ventricular mass at autopsy, making it possible that 
ECG findings were distorted by metabolic onsequences of the 
terminal i lness. Although there is a strong correlation between 
echocardiographic and autopsy left ventricular mass (42), and 
ECG variables have been similarly related to necropsy and 
echocardiographic left ventricular mass in previous studies 
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(11,12), the present findings should be confirmed in patients, 
using echocardiographically determined left ventricular mass. 
The lower overall performance of Sokolow-Lyon criteria 
and the Romhilt-Estes point score relative to the performance 
of Cornell voltage criteria in the present study could in part be 
due to a higher prevalence of concentric than eccentric hyper- 
trophy in the study group. Previous studies utilizing echocar- 
diographic left ventricular mass determinations have demon- 
strated that performance of Cornell criteria is lower in patients 
with eccentric hypertrophy (20,37,43) and higher in those with 
a greater prevalence of concentric hypertrophy (11,12). How- 
ever, the determination f left ventricular mass at autopsy-- 
when postmortem contracture variably changes wall thickness 
and chamber dimensions from those present during life 
(42,44)--precludes analysis in the present study of the relation 
of test performance to the geometric patterns of hypertrophy 
in these patients. 
Clinical implications. Left ventricular mass indexed to 
body surface area and to height have both predicted adverse 
cardiovascular outcome in a variety of patient groups (1-4,45), 
and further improvement i  risk stratification may be obtained 
by indexing left ventricular mass by measures of body size to 
the allometrically correct power (25). The current data argue 
that until the optimal method of indexing echocardiographic 
left ventricular mass for body size can be determined, the 
Cornell product provides a combination of the best test 
accuracy relative to the other criteria tested combined with low 
variability of performance asa function of hypertrophy defini- 
tion. Additional evaluation of other newly proposed ECG 
criteria, such as the time-voltage integral of the QRS complex 
(46), according to hypertrophy definition, will be necessary to 
define more precisely their diagnostic value in relation both to 
refinement of echocardiographic criteria for left ventricular 
hypertrophy and to the presence or absence of obesity. How- 
ever, the present data suggest that either the Cornell product 
or Cornell multivariate score provides more stable sensitivity 
for left ventricular hypertrophy, independent of the presence 
or absence of obesity, than adjusted Cornell voltage. 
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